Key result
Intracranial atherosclerotic stenosis linked to ~46% higher rates of minimal 90-day disability after stroke thrombectomy.
Why the study?
Can CT Perfusion metrics predict Intracranial Atherosclerotic Stenosis in patients with acute ischemic stroke undergoing endovascular therapy?
Observational (n=224)
No
Can CT Perfusion metrics predict Intracranial Atherosclerotic Stenosis in patients with acute ischemic stroke undergoing endovascular therapy?
Absolute Event Rate: 53% vs 36.3%
p-value: p=0.0122
CT perfusion parameters combined with clinical manifestations can help predict intracranial atherosclerotic stenosis in acute ischemic stroke patients undergoing endovascular therapy.
BACKGROUND: Intracranial Atherosclerotic Stenosis (ICAS) is a prevalent etiology of acute ischemic stroke (AIS), leading to significant morbidity and mortality. The accurate diagnosis and treatment of ICAS-induced AIS are critical to improving outcomes. This study assesses the application of Computed Tomography Perfusion (CTP) in predicting ICAS in AIS patients and its potential impact on patient management. METHODS: A retrospective analysis was conducted on 224 AIS patients who underwent endovascular therapy (EVT) at one single Chinese Stroke Center between April 2022 and December 2023. Clinical and radiological data were collected, including patients' demographics, CTP parameters, and 90-day modified Rankin Scale (mRS) scores. Logistic regression and receiver operating characteristic (ROC) curves evaluated the predictive power of CTP parameters for ICAS. RESULTS: >6s: Other Causes: 132.4 [70.5, 183.3] mL, ICAS: 96.3 [79.8, 107.3] mL, p =0.0064; relative cerebral blood flow, rCBF<30%: Other Causes: 2.4 [0.0, 10.8] mL, ICAS: 0.6 [0.0, 7.0] mL, p =0.0145; mismatch ratio: 7.4 [2.5, 15.0], ICAS: 11.0 [4.6, 17.8], p =0.0285], indicating more salvageable brain tissue. The 90-day mRS showed better functional outcomes in the ICAS group, with a higher likelihood of minimal to no disability [mRS 90 equals 0-1: ICAS: 53.0% vs. Other Causes: 36.3%, p =0.0122]. The predictive model for ICAS, combining clinical manifestations and CTP parameters, yielded an area under the curve (AUC) of 0.7779, demonstrating good diagnostic performance. CONCLUSION: CTP is a valuable diagnostic tool for ICAS-induced AIS, offering the potential for early identification and informing the decision for endovascular treatment. The positive correlation between CTP findings and patient outcomes supports its utility in clinical practice.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2024) conducted an observational in Acute ischemic stroke (AIS) (n=224). Intracranial Atherosclerotic Stenosis (ICAS) vs. Other causes of acute ischemic stroke was evaluated on Minimal to no disability (mRS 0-1) at 90 days (p=0.0122). Among acute ischemic stroke patients undergoing endovascular therapy, those with intracranial atherosclerotic stenosis had a higher rate of minimal to no disability at 90 days (53.0% vs. 36.3%, p=0.0122).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: